Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?

Wise investors are placing some biotech stocks on their watchlists this month, as these companies have surged over 160%. With more predicted upside to these companies than we see today, one could book some serious capital appreciation into a portfolio. The broader biotech industry is brimming with significant potential, making incredible advancements. Innovations span fields like drug discovery, gene editing, regenerative medicine and diagnostics. These technologies hold promise to treat a wide range of diseases, improving quality of life for many patients. Although investing in these companies is very risky, finding a biotech company that’s doing well can be like finding a needle in a haystack. These companies that are already trending have momentum on their side. So, ultimately, they could shoot off to higher highs throughout 2024. So for those who have a high risk tolerance, examine three biotech stocks that are up over 160%. Alpine Immune Sciences (ALPN) Source: Shutterstock Alpine Immune Sciences (NASDAQ: ALPN ) is up over 238% year-to-date ( YTD ), with no sign of slowing down....

InvestorPlace - 4/15/2024 3:43:32 PM More News for VRTX
Stock Analysis for VRTX
Related Stocks: VRTX,0QZU-LN,VX1-GF,VX1-GM,VX1-GY,VX1-GH,VX1-GS,VX1-GI,VX1-GD,VX1-GB,FDA-IM,ALPN,ENTX,ENTX,RZLT